Total Payments
$4,184
2024 Payments
$396.92
Companies
12
Transactions
33
Medicare Patients
548
Medicare Billing
$57,547
Payment Breakdown by Category
Food & Beverage$2,778 (66.4%)
Travel$1,406 (33.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,778 | 30 | 66.4% |
| Travel and Lodging | $1,406 | 3 | 33.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,748 | 7 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $693.56 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $430.69 | 5 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $285.89 | 3 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $242.69 | 2 | $0 (2019) |
| Amgen Inc. | $166.67 | 2 | $0 (2018) |
| Allergan, Inc. | $151.63 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $127.72 | 2 | $0 (2023) |
| BARD PERIPHERAL VASCULAR, INC. | $120.06 | 1 | $0 (2019) |
| Relypsa, Inc. | $116.27 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $396.92 | 4 | Bayer Healthcare Pharmaceuticals Inc. ($285.89) |
| 2023 | $115.43 | 1 | Janssen Pharmaceuticals, Inc ($115.43) |
| 2022 | $223.24 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($223.24) |
| 2019 | $615.64 | 7 | Allergan, Inc. ($125.00) |
| 2018 | $549.63 | 6 | Amgen Inc. ($166.67) |
| 2017 | $2,283 | 13 | Medtronic Vascular, Inc. ($1,748) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 06/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Cardio-renal | ||||||
| 06/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $111.03 | General |
| Category: DIABETES | ||||||
| 05/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Cardio-renal | ||||||
| 06/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $115.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $108.07 | General |
| Category: DIABETES | ||||||
| 09/07/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $115.17 | General |
| Category: DIABETES | ||||||
| 10/22/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: DIABETES | ||||||
| 08/26/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/04/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $124.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $92.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/26/2019 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/02/2019 | BARD PERIPHERAL VASCULAR, INC. | LUTONIX (Device) | Food and Beverage | In-kind items and services | $120.06 | General |
| Category: PERIPHERAL VASCULAR | ||||||
| 11/29/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $116.27 | General |
| Category: Hyperkalemia | ||||||
| 08/28/2018 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $118.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/23/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $85.88 | General |
| Category: Neuroscience | ||||||
| 05/15/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $121.45 | General |
| Category: DIABETES | ||||||
| 04/19/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $80.79 | General |
| Category: Endocrinology | ||||||
| 04/11/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/13/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $108.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/26/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $101.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $112.89 | General |
| Category: DIABETES | ||||||
| 05/10/2017 | Stryker Corporation | Trevo (Device) | Food and Beverage | Cash or cash equivalent | $84.72 | General |
| Category: Microcatheter/Stentriever | ||||||
| 03/02/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 89 | 181 | $14,755 | $9,608 |
| 2022 | 3 | 82 | 197 | $13,650 | $8,910 |
| 2021 | 5 | 161 | 350 | $27,050 | $18,231 |
| 2020 | 7 | 216 | 446 | $31,610 | $20,798 |
Total Patients
548
Total Services
1,174
Medicare Billing
$57,547
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 76 | $6,840 | $4,550 | 66.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 34 | $4,760 | $2,811 | 59.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $2,880 | $1,977 | 68.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 55 | $275.00 | $269.50 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 114 | $10,260 | $6,560 | 63.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $3,060 | $2,154 | 70.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 66 | $330.00 | $196.02 | 59.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 131 | $11,720 | $8,511 | 72.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 64 | $8,660 | $5,089 | 58.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 33 | 33 | $5,940 | $4,256 | 71.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 39 | 110 | $550.00 | $330.00 | 60.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 11 | 12 | $180.00 | $45.50 | 25.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 145 | $15,950 | $10,881 | 68.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 35 | 35 | $6,300 | $3,923 | 62.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 81 | $6,480 | $3,845 | 59.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 27 | $1,460 | $1,146 | 78.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 45 | 122 | $610.00 | $363.54 | 59.6% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 17 | 18 | $360.00 | $348.72 | 96.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 18 | $450.00 | $290.68 | 64.6% |
About Dionisio Calvo
Dionisio Calvo is a Internal Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487756094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dionisio Calvo has received a total of $4,184 in payments from pharmaceutical and medical device companies, with $396.92 received in 2024. These payments were reported across 33 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,778).
As a Medicare-enrolled provider, Calvo has provided services to 548 Medicare beneficiaries, totaling 1,174 services with total Medicare billing of $57,547. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Weslaco, TX
- Active Since 09/03/2006
- Last Updated 04/26/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487756094
Products in Payments
- JARDIANCE (Drug) $693.56
- ENTRESTO (Drug) $430.69
- Kerendia (Drug) $285.89
- PRALUENT (Drug) $242.69
- AVYCAZ (Drug) $151.63
- XARELTO (Drug) $127.72
- LUTONIX (Device) $120.06
- Veltassa (Drug) $116.27
- Aimovig (Biological) $85.88
- Trevo (Device) $84.72
- Prolia (Biological) $80.79
- DIFICID (Drug) $16.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Weslaco
Hector Amaya Chinchilla, M.d, M.D
Internal Medicine — Payments: $5,736
Internal Medicine $5,736
Dr. Claudia Pierson, M.d, M.D
Internal Medicine — Payments: $3,969
Internal Medicine $3,969
Pedro Penalo, Md, MD
Internal Medicine — Payments: $3,559
Internal Medicine $3,559
Dr. Robert Sepulveda, M.d, M.D
Internal Medicine — Payments: $2,673
Internal Medicine $2,673
Jesus Rodriguez Hernandez, M.d, M.D
Internal Medicine — Payments: $2,593
Internal Medicine $2,593
Dr. Amrit Sraow, M.d, M.D
Internal Medicine — Payments: $1,916
Internal Medicine $1,916